Laura and Isaac Perlmutter Cancer Center at NYU Langone
New York, New York, United States
Medical center in New York City, New York
240 E 38th St 19th Floor, New York, NY 10016
About Laura and Isaac Perlmutter Cancer Center at NYU Langone
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
National Cancer Institute (NCI)
148
Children's Oncology Group
81
NYU Langone Health
75
Eastern Cooperative Oncology Group
23
SWOG Cancer Research Network
19
Alliance for Clinical Trials in Oncology
18
Hoffmann-La Roche
16
Pfizer
12
Bristol-Myers Squibb
11
ECOG-ACRIN Cancer Research Group
10
Radiation Therapy Oncology Group
10
Clinical Trials at Laura and Isaac Perlmutter Cancer Center at NYU Langone
During the past decade, Laura and Isaac Perlmutter Cancer Center at NYU Langone conducted 239 clinical trials. In the 10-year time frame, 239 clinical trials started and 176 clinical trials were completed, i.e. on
average, 73.6% percent of trials that started reached the finish line to date. In the past 5 years, 62 clinical trials started and 75 clinical trials were completed. i.e. 121%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Radiation Therapy Plus Topotecan in Treating Patients With Non-small Cell Lung Cancer
1993-09-01
Completed
20
SWOG-9321 Melphalan, TBI, and Transplant vs Combo Chemo in Untreated Myeloma
1994-01-01
2006-11-01
Completed
899
Paclitaxel Plus Topotecan in Treating Patients With Solid Tumors
1994-09-01
2000-12-01
Completed
20
Combination Chemotherapy in Treating Children With Lymphoma
1994-07-01
2007-03-01
Completed
221
High-Dose Folic Acid in Preventing Colorectal Cancer in Patients Who Have Had Polyps Surgically Removed
1995-04-01
2009-05-01
Completed
80
Aminocamptothecin in Treating Patients With Recurrent or Unresectable Epithelial Ovarian Cancer
1995-12-01
Completed
Radiation Therapy With or Without Radiosurgery in Treating Patients With Brain Metastases
1996-01-01
2004-12-01
Completed
333
Induction Intensification in Treating Infants With Newly Diagnosed Acute Lymphoblastic Leukemia
1996-06-01
2012-03-01
Completed
221
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Laura and Isaac Perlmutter Cancer Center at NYU Langone" #1 sponsor was "National Cancer Institute (NCI)" with 148 trials, followed by "Children's Oncology Group" with 81 trials
sponsored, "NYU Langone Health" with 75 trials sponsored, "Eastern Cooperative Oncology Group" with 23 trials sponsored and "SWOG Cancer Research Network"
with 23 trials sponsored. Other sponsors include 270 different institutions and
companies that sponsored additional 128 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Laura and Isaac Perlmutter Cancer Center at NYU Langone"
#1 collaborator was "National Cancer Institute (NCI)" with 233 trials as a collaborator, "NRG Oncology" with 26 trials as a collaborator, "Merck Sharp & Dohme LLC" with 12 trials as a collaborator, "Cancer and Leukemia Group B" with 11 trials as a collaborator and "SWOG Cancer Research Network" with 11 trials as a collaborator. Other collaborators include 183 different institutions and companies that were
collaborators in the rest 106 trials.
Clinical Trials Conditions at Laura and Isaac Perlmutter Cancer Center at NYU Langone
According to Clinical.Site data, the most researched conditions in "Laura and Isaac Perlmutter Cancer Center at NYU Langone" are
"Breast Cancer" (34 trials), "Ovarian Cancer" (25 trials), "Colorectal Cancer" (22 trials), "Leukemia" (22 trials) and "Lymphoma" (21 trials). Many other conditions were trialed in "Laura and Isaac Perlmutter Cancer Center at NYU Langone" in a lesser frequency.
Clinical Trials Intervention Types at Laura and Isaac Perlmutter Cancer Center at NYU Langone
Most popular intervention types in "Laura and Isaac Perlmutter Cancer Center at NYU Langone" are "Drug" (504 trials), "Other" (185 trials), "Biological" (179 trials), "Procedure" (131 trials) and "Radiation" (109 trials). Other intervention types were less common.
The name of intervention was led by "Laboratory Biomarker Analysis" (98 trials), "Quality-of-Life Assessment" (55 trials), "Carboplatin" (48 trials), "Cyclophosphamide" (41 trials) and "Questionnaire Administration" (39 trials). Other intervention names were less common.
Clinical Trials Genders at Laura and Isaac Perlmutter Cancer Center at NYU Langone
The vast majority of trials in "Laura and Isaac Perlmutter Cancer Center at NYU Langone" are
507 trials for "All" genders, 88 trials for "Female" genders and 26 trials for "Male" genders.
Clinical Trials Status at Laura and Isaac Perlmutter Cancer Center at NYU Langone
Currently, there are NaN active trials in "Laura and Isaac Perlmutter Cancer Center at NYU Langone".
undefined are not yet recruiting,
103 are recruiting,
150 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 294 completed trials in Laura and Isaac Perlmutter Cancer Center at NYU Langone,
6 suspended trials,
and 51 terminated clinical trials to date.
Out of the total trials that were conducted in Laura and Isaac Perlmutter Cancer Center at NYU Langone, 126 "Phase 1"
clinical trials were conducted, 295 "Phase 2" clinical
trials and 210 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 2 trials, and there were
also 25 trials that are defined as “Not Applicable".